1. World Health Organization. Mental health action plan 2013–2020. 2013[cited 2019 Jul 04]. Available from: http://www.who.int/mental_health/publications/action_plan/en/ 
2. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153-60. https://doi.org/10.1002/wps.20128 https://pubmed.ncbi.nlm.nih.gov/24890068 
3. Bondy B, Buettner A, Zill P. Genetics of suicide. Mol Psychiatry. 2006;11(4):336-51. https://doi.org/10.1038/sj.mp.4001803 https://pubmed.ncbi.nlm.nih.gov/16462816 
4. Sadkowski M, Dennis B, Clayden RC, Elsheikh W, Rangarajan S, Dejesus J, et al. The role of the serotonergic system in suicidal behavior. Neuropsychiatr Dis Treat. 2013;9:1699-716. https://pubmed.ncbi.nlm.nih.gov/24235834 
5. Varga G, Szekely A, Sasvari-Szekely M. Candidate gene studies of dopaminergic and serotonergic polymorphisms. Neuropsychopharmacologia Hungarica. 2011;13(42):93-101. https://pubmed.ncbi.nlm.nih.gov/21677323 
6. Kim YK, Hwang JA, Lee HJ, Yoon HK, Ko YH, Lee BH, et al. Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder. J Affect Disord. 2014;158:127-32. https://doi.org/10.1016/j.jad.2014.01.018 https://pubmed.ncbi.nlm.nih.gov/24655776 
7. Nagy C, Suderman M, Yang J, Szyf M, Mechawar N, Ernst C, et al. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol Psychiatry. 2015;20(3):320-8. https://doi.org/10.1038/mp.2014.21 https://pubmed.ncbi.nlm.nih.gov/24662927 
8. Pregelj P, Nedic G, Paska AV, Zupanc T, Nikolac M, Balažic J, et al. The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. J Affect Disord. 2011;128(3):287-90. https://doi.org/10.1016/j.jad.2010.07.001 https://pubmed.ncbi.nlm.nih.gov/20667416 
9. Pungercic G, Videtic A, Pestotnik A, Pajnic IZ, Zupanc T, Balazic J, et al. Serotonin transporter gene promoter (5-HTTLPR) and intron 2 (VNTR) polymorphisms: a study on Slovenian population of suicide victims. Psychiatr Genet. 2006;16(5):187-91. https://doi.org/10.1097/01.ypg.0000218617.65633.9e https://pubmed.ncbi.nlm.nih.gov/16969272 
10. Uršič K, Zupanc T, Paska AV. Analysis of promoter polymorphism in monoamine oxidase A (MAOA) gene in completed suicide on Slovenian population. Neurosci Lett. 2018;673:111-5. https://doi.org/10.1016/j.neulet.2018.02.063 https://pubmed.ncbi.nlm.nih.gov/29505805 
11. Videtic A, Peternelj TT, Zupanc T, Balazic J, Komel R. Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav. 2009;8(5):541-5. https://doi.org/10.1111/j.1601-183X.2009.00505.x https://pubmed.ncbi.nlm.nih.gov/19496825 
12. Videtic A, Zupanc T, Pregelj P, Balazic J, Tomori M, Komel R. Suicide, stress and serotonin receptor 1A promoter polymorphism -1019C>G in Slovenian suicide victims. Eur Arch Psychiatry Clin Neurosci. 2009;259(4):234-8. https://doi.org/10.1007/s00406-008-0861-4 https://pubmed.ncbi.nlm.nih.gov/19224112 
13. Zupanc T, Pregelj P, Paska AV. Tryptophan hydroxylase 2 (TPH 2) single nucleotide polymorphisms, suicide, and alcohol-related suicide. Psychiatr Danub. 2013;25:S332-6. https://pubmed.ncbi.nlm.nih.gov/23995203 
14. Zupanc T, Pregelj P, Tomori M, Komel R, Paska AV. TPH2 polymorphisms and alcohol-related suicide. Neurosci Lett. 2011;490(1):78-81. https://doi.org/10.1016/j.neulet.2010.12.030 https://pubmed.ncbi.nlm.nih.gov/21182896 
15. van Vliet J, Oates NA, Whitelaw E. Epigenetic mechanisms in the context of complex diseases. Cell Mol Life Sci. 2007;64(12):1531-8. https://doi.org/10.1007/s00018-007-6526-z https://pubmed.ncbi.nlm.nih.gov/17458502 
16. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(3s):245-54. https://doi.org/10.1038/ng1089 https://pubmed.ncbi.nlm.nih.gov/12610534 
17. Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823-6. https://doi.org/10.1016/S0092-8674(01)00616-X https://pubmed.ncbi.nlm.nih.gov/11779458 
18. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843-54. https://doi.org/10.1016/0092-8674(93)90529-Y https://pubmed.ncbi.nlm.nih.gov/8252621 
19. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901-6. https://doi.org/10.1038/35002607 https://pubmed.ncbi.nlm.nih.gov/10706289 
20.  . miRBase database: University of Manchester. [cited 2017 Jul 4]. Available from: http://www.mirbase.org 
21. Millar AA, Waterhouse PM. Plant and animal microRNAs: similarities and differences. Funct Integr Genomics. 2005;5(3):129-35. https://doi.org/10.1007/s10142-005-0145-2 https://pubmed.ncbi.nlm.nih.gov/15875226 
22. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002;21(17):4663-70. https://doi.org/10.1093/emboj/cdf476 https://pubmed.ncbi.nlm.nih.gov/12198168 
23. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92-105. https://doi.org/10.1101/gr.082701.108 https://pubmed.ncbi.nlm.nih.gov/18955434 
24. Kawamata T, Seitz H, Tomari Y. Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol. 2009;16(9):953-60. https://doi.org/10.1038/nsmb.1630 https://pubmed.ncbi.nlm.nih.gov/19684602 
25. Okamura K, Phillips MD, Tyler DM, Duan H, Chou YT, Lai EC. The regulatory activity of microRNA* species has substantial influence on microRNA and 3′ UTR evolution. Nat Struct Mol Biol. 2008;15(4):354-63. https://doi.org/10.1038/nsmb.1409 https://pubmed.ncbi.nlm.nih.gov/18376413 
26. Hu HY, Yan Z, Xu Y, Hu H, Menzel C, Zhou YH, et al. Sequence features associated with microRNA strand selection in humans and flies. BMC Genomics. 2009;10(1):413. https://doi.org/10.1186/1471-2164-10-413 https://pubmed.ncbi.nlm.nih.gov/19732433 
27. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, et al. SNPs in human miRNA genes affect biogenesis and function. RNA. 2009;15(9):1640-51. https://doi.org/10.1261/rna.1560209 https://pubmed.ncbi.nlm.nih.gov/19617315 
28. Xhemalce B, Robson SC, Kouzarides T. Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell. 2012;151(2):278-88. https://doi.org/10.1016/j.cell.2012.08.041 https://pubmed.ncbi.nlm.nih.gov/23063121 
29. Li Y, Kowdley KV. MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics. 2012;10(5):246-53. https://doi.org/10.1016/j.gpb.2012.07.005 https://pubmed.ncbi.nlm.nih.gov/23200134 
30. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9(16):2395-402. https://doi.org/10.1093/hmg/9.16.2395 https://pubmed.ncbi.nlm.nih.gov/11005794 
31. Prokhortchouk E, Defossez PA. The cell biology of DNA methylation in mammals. Biochim Biophys Acta. 2008;1783(11):2167-73. https://doi.org/10.1016/j.bbamcr.2008.07.015 https://pubmed.ncbi.nlm.nih.gov/18706939 
32. Illingworth RS, Bird AP. CpG islands—‘a rough guide’. FEBS Lett. 2009;583(11):1713-20. https://doi.org/10.1016/j.febslet.2009.04.012 https://pubmed.ncbi.nlm.nih.gov/19376112 
33. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6-21. https://doi.org/10.1101/gad.947102 https://pubmed.ncbi.nlm.nih.gov/11782440 
34. Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472-9. https://doi.org/10.1038/nature12750 https://pubmed.ncbi.nlm.nih.gov/24153300 
35. Gräff J, Mansuy IM. Epigenetic codes in cognition and behaviour. Behav Brain Res. 2008;192(1):70-87. https://doi.org/10.1016/j.bbr.2008.01.021 https://pubmed.ncbi.nlm.nih.gov/18353453 
36. Pidsley R, Mill J. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry. 2011;69(2):146-56. https://doi.org/10.1016/j.biopsych.2010.03.029 https://pubmed.ncbi.nlm.nih.gov/20510393 
37. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82(3):696-711. https://doi.org/10.1016/j.ajhg.2008.01.008 https://pubmed.ncbi.nlm.nih.gov/18319075 
38. Melka MG, Castellani CA, Rajakumar N, O’Reilly R, Singh SM. Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis. BMC Neurosci. 2014;15(1):112. https://doi.org/10.1186/1471-2202-15-112 https://pubmed.ncbi.nlm.nih.gov/25266742 
39. Asai T, Bundo M, Sugawara H, Sunaga F, Ueda J, Tanaka G, et al. Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol. 2013;16(10):2285-94. https://doi.org/10.1017/S1461145713000710 https://pubmed.ncbi.nlm.nih.gov/23931339 
40. Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, Uhr M, et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology. 2010;35(3):792-805. https://doi.org/10.1038/npp.2009.188 https://pubmed.ncbi.nlm.nih.gov/19924110 
41. Zimmermann N, Zschocke J, Perisic T, Yu S, Holsboer F, Rein T. Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem J. 2012;448(1):93-102. https://doi.org/10.1042/BJ20120674 https://pubmed.ncbi.nlm.nih.gov/22880885 
42. Le François B, Soo J, Millar AM, Daigle M, Le Guisquet AM, Leman S, et al. Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 site. Neurobiol Dis. 2015;82:332-41. https://doi.org/10.1016/j.nbd.2015.07.002 https://pubmed.ncbi.nlm.nih.gov/26188176 
43. Melas PA, Rogdaki M, Lennartsson A, Björk K, Qi H, Witasp A, et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol. 2012;15(5):669-79. https://doi.org/10.1017/S1461145711000940 https://pubmed.ncbi.nlm.nih.gov/21682946 
44. Wei Y, Melas PA, Wegener G, Mathé AA, Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int J Neuropsychopharmacol. 2014;18(2):pyu032. https://doi.org/10.1093/ijnp/pyu032 https://pubmed.ncbi.nlm.nih.gov/25618518 
45. Sun H, Kennedy PJ, Nestler EJ. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology. 2013;38(1):124-37. https://doi.org/10.1038/npp.2012.73 https://pubmed.ncbi.nlm.nih.gov/22692567 
46. Kornberg RD, Thomas JO. Chromatin structure; oligomers of the histones. Science. 1974;184(4139):865-8. https://doi.org/10.1126/science.184.4139.865 https://pubmed.ncbi.nlm.nih.gov/4825888 
47. Arents G, Moudrianakis EN. The histone fold: a ubiquitous architectural motif utilized in DNA compaction and protein dimerization. Proc Natl Acad Sci USA. 1995;92(24):11170-4. https://doi.org/10.1073/pnas.92.24.11170 https://pubmed.ncbi.nlm.nih.gov/7479959 
48. Davey CA, Sargent DF, Luger K, Maeder AW, Richmond TJ. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. J Mol Biol. 2002;319(5):1097-113. https://doi.org/10.1016/S0022-2836(02)00386-8 https://pubmed.ncbi.nlm.nih.gov/12079350 
49. Mariño-Ramírez L, Kann MG, Shoemaker BA, Landsman D. Histone structure and nucleosome stability. Expert Rev Proteomics. 2005;2(5):719-29. https://doi.org/10.1586/14789450.2.5.719 https://pubmed.ncbi.nlm.nih.gov/16209651 
50. Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta. 2014;1839(8):627-43. https://doi.org/10.1016/j.bbagrm.2014.03.001 https://pubmed.ncbi.nlm.nih.gov/24631868 
51. Peterson CL, Laniel MA. Histones and histone modifications. Curr Biol. 2004;14(14):R546-51. https://doi.org/10.1016/j.cub.2004.07.007 https://pubmed.ncbi.nlm.nih.gov/15268870 
52. Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov. 2008;7(10):854-68. https://doi.org/10.1038/nrd2681 https://pubmed.ncbi.nlm.nih.gov/18827828 
53. Wang Y, Xia J, Helfer B, Li C, Leucht S. Valproate for schizophrenia. Cochrane Database Syst Rev. 2016;11:CD004028. https://pubmed.ncbi.nlm.nih.gov/27884042 
54. Misztak P, Pańczyszyn-Trzewik P, Sowa-Kućma M. Histone deacetylases (HDACs) as therapeutic target for depressive disorders. Pharmacol Rep. 2018;70(2):398-408. https://doi.org/10.1016/j.pharep.2017.08.001 https://pubmed.ncbi.nlm.nih.gov/29456074 
55. Machado-Vieira R, Ibrahim L, Zarate CA. Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions. CNS Neurosci Ther. 2011;17(6):699-704. https://doi.org/10.1111/j.1755-5949.2010.00203.x https://pubmed.ncbi.nlm.nih.gov/20961400 
56. Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S. The potential use of histone deacetylase inhibitors in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:320-4. https://doi.org/10.1016/j.pnpbp.2015.03.010 https://pubmed.ncbi.nlm.nih.gov/25818247 
57. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41-5. https://doi.org/10.1038/47412 https://pubmed.ncbi.nlm.nih.gov/10638745 
58. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007;128(4):707-19. https://doi.org/10.1016/j.cell.2007.01.015 https://pubmed.ncbi.nlm.nih.gov/17320508 
59. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057-68. https://doi.org/10.1038/nbt.1685 https://pubmed.ncbi.nlm.nih.gov/20944598 
60. Nestler EJ, Peña CJ, Kundakovic M, Mitchell A, Akbarian S. Epigenetic Basis of Mental Illness. Neuroscientist. 2016;22(5):447-63. https://doi.org/10.1177/1073858415608147 https://pubmed.ncbi.nlm.nih.gov/26450593 
61. Maussion G, Yang J, Yerko V, Barker P, Mechawar N, Ernst C, et al. Regulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completers. PLoS One. 2012;7(6):e39301. https://doi.org/10.1371/journal.pone.0039301 https://pubmed.ncbi.nlm.nih.gov/22802923 
62. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68(7):2094-105. https://doi.org/10.1158/0008-5472.CAN-07-5194 https://pubmed.ncbi.nlm.nih.gov/18381414 
63. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA. 2008;14(5):872-7. https://doi.org/10.1261/rna.972008 https://pubmed.ncbi.nlm.nih.gov/18367714 
64. Smalheiser NR, Lugli G, Rizavi HS, Torvik VI, Turecki G, Dwivedi Y. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One. 2012;7(3):e33201. https://doi.org/10.1371/journal.pone.0033201 https://pubmed.ncbi.nlm.nih.gov/22427989 
65. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37(Database issue):D105-10. https://doi.org/10.1093/nar/gkn851 https://pubmed.ncbi.nlm.nih.gov/18996891 
66. Fiori LM, Turecki G. Implication of the polyamine system in mental disorders. J Psychiatry Neurosci. 2008;33(2):102-10. https://pubmed.ncbi.nlm.nih.gov/18330456 
67. Lopez JP, Fiori LM, Gross JA, Labonte B, Yerko V, Mechawar N, et al. Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers. Int J Neuropsychopharmacol. 2014;17(1):23-32. https://doi.org/10.1017/S1461145713000941 https://pubmed.ncbi.nlm.nih.gov/24025154 
68. Pantazatos SP, Andrews SJ, Dunning-Broadbent J, Pang J, Huang YY, Arango V, et al. Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide. Neurobiol Dis. 2015;79:123-34. https://doi.org/10.1016/j.nbd.2015.04.014 https://pubmed.ncbi.nlm.nih.gov/25959060 
69. Pantazatos SP, Huang YY, Rosoklija GB, Dwork AJ, Arango V, Mann JJ. Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity. Mol Psychiatry. 2017;22(5):760-73. https://doi.org/10.1038/mp.2016.130 https://pubmed.ncbi.nlm.nih.gov/27528462 
70. Roy B, Wang Q, Palkovits M, Faludi G, Dwivedi Y. Altered miRNA expression network in locus coeruleus of depressed suicide subjects. Sci Rep. 2017;7(1):4387. https://doi.org/10.1038/s41598-017-04300-9 https://pubmed.ncbi.nlm.nih.gov/28663595 
71. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135-45. https://doi.org/10.1038/nbt1486 https://pubmed.ncbi.nlm.nih.gov/18846087 
72. Labonté B, Suderman M, Maussion G, Lopez JP, Navarro-Sánchez L, Yerko V, et al. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry. 2013;170(5):511-20. https://doi.org/10.1176/appi.ajp.2012.12050627 https://pubmed.ncbi.nlm.nih.gov/23511308 
73. Haghighi F, Xin Y, Chanrion B, O’Donnell AH, Ge Y, Dwork AJ, et al. Increased DNA methylation in the suicide brain. Dialogues Clin Neurosci. 2014;16(3):430-8. https://pubmed.ncbi.nlm.nih.gov/25364291 
74. Schneider E, El Hajj N, Müller F, Navarro B, Haaf T. Epigenetic Dysregulation in the Prefrontal Cortex of Suicide Completers. Cytogenet Genome Res. 2015;146(1):19-27. https://doi.org/10.1159/000435778 https://pubmed.ncbi.nlm.nih.gov/26160260 
75. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry. 2010;67(3):258-67. https://doi.org/10.1001/archgenpsychiatry.2010.9 https://pubmed.ncbi.nlm.nih.gov/20194826 
76. McGowan PO, Sasaki A, Huang TC, Unterberger A, Suderman M, Ernst C, et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One. 2008;3(5):e2085. https://doi.org/10.1371/journal.pone.0002085 https://pubmed.ncbi.nlm.nih.gov/18461137 
77. Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V, et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res. 2011;129(2-3):183-90. https://doi.org/10.1016/j.schres.2011.04.007 https://pubmed.ncbi.nlm.nih.gov/21550210 
78. Ernst C, Deleva V, Deng X, Sequeira A, Pomarenski A, Klempan T, et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry. 2009;66(1):22-32. https://doi.org/10.1001/archpsyc.66.1.22 https://pubmed.ncbi.nlm.nih.gov/19124685 
79. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 2012;13(6):R43. https://doi.org/10.1186/gb-2012-13-6-r43 https://pubmed.ncbi.nlm.nih.gov/22703893 
80. Aberg KA, Xie LY, McClay JL, Nerella S, Vunck S, Snider S, et al. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics. 2013;5(4):367-77. https://doi.org/10.2217/epi.13.36 https://pubmed.ncbi.nlm.nih.gov/23895651 
81. Ernst C, Chen ES, Turecki G. Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Mol Psychiatry. 2009;14(9):830-2. https://doi.org/10.1038/mp.2009.35 https://pubmed.ncbi.nlm.nih.gov/19696771 
82. Fiori LM, Turecki G. Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers. Int J Neuropsychopharmacol. 2010;13(6):725-36. https://doi.org/10.1017/S1461145709991167 https://pubmed.ncbi.nlm.nih.gov/20059804 
83. Fiori LM, Turecki G. Epigenetic regulation of spermidine/spermine N1-acetyltransferase (SAT1) in suicide. J Psychiatr Res. 2011;45(9):1229-35. https://doi.org/10.1016/j.jpsychires.2011.03.015 https://pubmed.ncbi.nlm.nih.gov/21501848 
84. Fiori LM, Gross JA, Turecki G. Effects of histone modifications on increased expression of polyamine biosynthetic genes in suicide. Int J Neuropsychopharmacol. 2012;15(8):1161-6. https://doi.org/10.1017/S1461145711001520 https://pubmed.ncbi.nlm.nih.gov/22008221 
